Corbus Pharmaceuticals Holdings, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported Increase (Decrease) in Prepaid Expense and Other Assets of $1.88 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2018-03-12
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2017 was $1.88M, a 239.14% increase from fiscal 2016.
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2016 was $553.75K, a 422.60% increase from fiscal 2015.
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2015 was $105.96K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|
| 2017-12-31 | $1.88M 10-K · filed 2018-03-12 |
| 2016-12-31 | $553.75K 10-K · filed 2018-03-12 |
| 2015-12-31 | $105.96K 10-K · filed 2018-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |